IP Shakti

ipshakti_fix_smallIP Shakti is the pre-eminent patent advisory and commercialization advisory service in the material science, energy, communications, electronics and medical device space.  IP Shakti provides exclusive patent advisory service for Fortune 500 companies in all fields of technology, discovering potential intellectual property assets with high value for monetization. IP Shakti collaborates with more than 80 universities around the world and is a leading edge company in early stage technology commercialization.

Partners & Products

shizuoka_university
carolina_kickstart

Testimonials

University inventions, resulting from research funding, typically need further development to make them more attractive to potential licensees. Some institutions have foundations, which provide funds for development of a prototype or proof of concept. This critical early stage investment need is well recognized by the investment community as well as economic development agencies. IPShakti could play a vital role in this niche.

We welcome the opportunity to develop a strategic relationship with an entity that can bring to bear a full range of technology assessment and development expertise (including business, intellectual property, regulatory, clinical), critical and timely pre-seed and follow-on funding, and a network necessary to transform lab discoveries into technologies that address important life science, biotech, and medical needs.

IPShakti is addressing a critical need in commercializing early-stage, university-generated innovations. Two things impress me about their model.  They bring more than funding to the table by taking a role in assessing the technology, building the management team, and the licensing the technology.  Secondly, they are deploying funds in a capital efficient process, focusing on the most critical experiments for de-risking the technology.

IPShakti is focusing on what is perhaps the most critical space for ensuring success in innovation-based business development.  Universities like the University of Virginia need partners like IPShakti to help us identify early stage discoveries with significant clinical and market potential; partner in proof-of-concept research; locate pre-seed and seed capital; and build business cases and management teams around these opportunities.

We welcome the opportunity to develop a strategic relationship with an entity that can bring to bear a full range of technology assessment and development expertise (including business, intellectual property, regulatory, clinical), critical and timely pre-seed and follow-on funding, and a network necessary to transform lab discoveries into technologies that address important life science, biotech, and medical needs.

IPShakti is addressing a critical need in commercializing early-stage, university-generated innovations. Two things impress me about their model.  They bring more than funding to the table by taking a role in assessing the technology, building the management team, and the licensing the technology.  Secondly, they are deploying funds in a capital efficient process, focusing on the most critical experiments for de-risking the technology.

University inventions, resulting from research funding, typically need further development to make them more attractive to potential licensees. Some institutions have foundations, which provide funds for development of a prototype or proof of concept. This critical early stage investment need is well recognized by the investment community as well as economic development agencies. IPShakti could play a vital role in this niche.

IPShakti is focusing on what is perhaps the most critical space for ensuring success in innovation-based business development.  Universities like the University of Virginia need partners like IPShakti to help us identify early stage discoveries with significant clinical and market potential; partner in proof-of-concept research; locate pre-seed and seed capital; and build business cases and management teams around these opportunities.

Patent Brokerage

IP Shakti’s experienced patent licensing and monetization experts can assist with patent brokerage, licensing and commercialization efforts.

Proof of Concept

IP Shakti provides proof of concept for medical devices and takes early stage technologies to market.

Patent Analytics

IP Shakti’s proprietary patent analytics platform can quickly identify top assets within a portfolio of 50 to 100,000 or more patent assets.  Both a spring board and starting strategy, the portfolio analysis becomes a useful tool for summarizing a huge amount of patent data while allowing focus on under-utilized portfolio segments.

Patent Advisory

IP Shakti’s technological and intellectual property experts can identify top monetization candidates within a patent portfolio, from both a patent and technology perspective.  IP Shakti’s advisory includes technological analysis, patent analysis, potential licensee analysis and financial analysis of potential monetization assets to produce a clear monetization picture.

News

Home

Updated on 2014-09-13T15:18:29+00:00, by tladmin.